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PERANAN DISFUNGSI ENDOTELIAL MIKROVASKULAR DAN GENETIK 
PADA KEPARAHAN DAN PERKEMBANGAN GLUKOMA SUDUT 
TERBUKA 
PRIMER DALAM KALANGAN ORANG MELAYU 
 
ABSTRAK 
 
Sehingga kini, pengetahuan terhadap persembahan klinikal dan faktor risiko untuk 
glaukoma sudut terbuka primer (POAG) dalam kalangan kaum Melayu masih 
kurang. Mengenalpasti faktor risiko yang berkaitan dengan tahap keterukan dan 
kadar keterukan penyakit. kadar keterukan POAG dalam kalangan kaum Melayu 
amat penting untuk merancang strategi pencegahan kebutaan dan rawatan yang lebih 
berkesan. Kajian ini dijalankan untuk menentukan tahap dan kadar keterukan POAG 
di kalangan pesakit POAG berbangsa Melayu. Selain dari itu, kajian ini juga 
bertujuan untuk menentukan peranan fungsi endotelial mikrovaskular dan genetik 
dalam menentukan tahap dan kadar keterukan POAG. 
Satu kajian keratan rentas telah dijalankan yang melibatkan 215 subjek berbangsa 
Melayu (114 pesakit POAG dan 101 kawalan). Keterukan POAG adalah berdasarkan 
analisa medan penglihatan Humphrey (HVF). Ketentuan kadar keterukan adalah 
berdasarkan kombinasi skor Kajian Intervensi Glaukoma Lanjutan (AGIS) dan 
klasifikasi Hodapp, Parish dan Anderson. Manakala tahap keterukan POAG adalah 
berdasarkan skor AGIS HVF yang telah diubah suai; tahap keterukan ringan, 
sederhana dan teruk.  
xxi 
 
Fungsi endotelial mikrovaskular juga turut dinilai menggunakan ‘Laser Doppler 
Fluximetry’ (LDF) dan proses iontoforesis mengunakan asetilkolina (ACh) dan 
natrium nitroprusida. Darah vena juga turut diambil dari pesakit glaukona bagi kajian 
genetik.  Ketulenan genom DNA yang tinggi juga telah diekstrakkan. Platform 
‘Microarray Human Omni Express-12’ telah digunakan untuk mengenalpasti 
penanda genetik bagi kadar keterukkan penyakit POAG. rs1392912 dan rs1660029 
dari gen KALRN, dan rs1210977 dari gen COL9A1 telah dikenalpasti sebagai 
penanda genetik yang berpotensi memainkan peranan dalam menentukan kadar 
keterukan penyakit  dan fungsi endotelial mikrovaskular. Polimorfisma nukleotida 
tunggal (SNPs) ini kemudiannya telah didedahkan kepada penjujukan DNA. 
Selepas purata 4.1 (3.0) tahun menjalani temujanji susulan didapati 35 pesakit 
menunjukkan perubahan dalam keterukan medan penglihatan. Berdasarkan kepada 
medan penglihatan semasa kajian ini dijalankan, 55 pesakit menunjukkan tahap 
POAG yang ringan, 29 sederhana dan 30 teruk. Terdapat pengurangan fungsi 
endotelial mikrovaskular yang signifikan dalam kalangan pesakit POAG berbanding 
kumpulan kawalan (p<0.001). Respon terhadap ACh dan s natrium nitroprusida 
berkurangan secara signifikan dalam kalangan pesakit yang mengalami POAG teruk 
(p<0.001). Terdapat juga pengurangan fungsi endotelial mikrovaskular yang 
signifikan di kalangan pesakit yang menunjukkan perubahan keterukan medan 
penglihatan (p<0.001). Didapati juga risiko perubahan keterukan penyakit POAG 
adalah 4.8 kali ganda (95% CI 1.52, 14.86) dalam kalangan pesakit dengan 
rs1392912GA dan 5.8 kali ganda (95% CI 1.85, 18.61) dalam kalangan pesakit 
dengan rs1660029AG. Walaubagaimana pun, tiada hubungkait variasi penanda 
xxii 
 
genetik rs1210977 dari COL9A1 dalam fungsi endotelial mikrovaskular pesakit 
Melayu yang menghidap POAG. 
Kadar keterukan penyakit POAG adalah 8.5 pesakit/tahun di kalangan pesakit 
Melayu. Fungsi endotelial mikrovaskular memainkan peranan dalam tahap dan kadar 
keterukan POAG dalam kalangan bangsa Melayu. rs1392912GA dari gen KALRN 
adalah penanda genetik yang berpotensi dalam menentukan perubahan keterukkan 
penyakit POAG. Terdapat kemungkinan bahawa penambahbaikan fungsi endotelial 
mikrovaskular dan pengesanan awal pesakit dengan variasi genetik gen KALRN 
dapat membantutkan kadar keterukan penyakit POAG dikalangan bangsa Melayu. 
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THE ROLE OF MICROVASCULAR ENDOTHELIAL DYSFUNCTION AND 
GENETICS ON SEVERITY AND PROGRESSION OF PRIMARY OPEN 
ANGLE GLAUCOMA IN MALAYS 
 
ABSTRACT 
 
There is lack of knowledge of clinical presentation and risk factor for primary open 
angle glaucoma (POAG) in Malays. Identification of the risk factors for severity and 
progression of POAG in Malays is important to strategies prevention of blindness 
and effective management. This study was conducted to determine the severity and 
progression of POAG in Malay patients and to determine the role of microvascular 
endothelial function and genetics in progression and severity of POAG.  
A cross-sectional study was conducted involving 215 Malay (114 POAG patients and 
101 controls) subjects. Progression was determined based on Humphrey visual field 
analysis (HVF) of 114 POAG patients using combination criteria of Advanced 
Glaucoma Intervention Study (AGIS) scoring and Hodapp, Parish and Anderson 
classification. Severity of POAG was based on modified AGIS scoring of HVF. 
Microvascular endothelial function was assessed using Laser Doppler Fluximetry 
(LDF) with the process of acetylcholine (ACh) and sodium nitroprusside 
iontophoresis. Venesection was also conducted. High purity genomic DNA was 
extracted. Microarray Human Omni Express-12 platform was used to identify genetic 
markers. rs1392912 and rs1660029 from KALRN gene, and rs1210977of COL9A1 
gene  were identified as potential markers for progression and microvascular 
xxiv 
 
endothelial function. These single nucleotide polymorphisms (SNPs) were then 
subjected to DNA sequencing. 
After the mean 4.1(3.0) years of follow up, 35 patients showed evidence of visual 
field progression. Based on HVF at recruitment, 55 patients were mild, 29 moderate 
and 30 severe POAG. There was significant reduction of microvascular endothelial 
function in POAG patients compared to control (p<0.001)). ACh and sodium 
nitroprusside response was significantly reduced in severe POAG (p<0.001).  There 
was significant reduction of microvascular endothelial function in patients who 
showed visual field progression (p<0.001). The risk of progression is 4.8 folds (95% 
CI 1.52, 14.86) in patients with rs1392912GA and 5.8folds (95% CI 1.85, 18.61) in 
patients with rs1660029AG. However, there was no association betweenrs1210977 
of COL9A1 and microvascular endothelial function of Malay patients with POAG 
The progression rate of POAG in Malay patients was 8.5 patients/year. 
Microvascular endothelial function play a role in progression and severity of POAG 
in Malays. rs1392912GA and rs1660029AG of KALRN gene are potential genetic 
markers for progression of glaucoma. Perhaps, improvement in microvascular 
endothelial function and early detection of patients with genetic variations of 
KALRN gene may retard the progression of POAG in Malays. 
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PERANAN DISFUNGSI ENDOTELIAL MIKROVASKULAR DAN GENETIK 
PADA KEPARAHAN DAN PERKEMBANGAN GLUKOMA SUDUT 
TERBUKA 
PRIMER DALAM KALANGAN ORANG MELAYU 
 
ABSTRAK 
 
Sehingga kini, pengetahuan terhadap persembahan klinikal dan faktor risiko untuk 
glaukoma sudut terbuka primer (POAG) dalam kalangan kaum Melayu masih 
kurang. Mengenalpasti faktor risiko yang berkaitan dengan tahap keterukan dan 
kadar keterukan penyakit. kadar keterukan POAG dalam kalangan kaum Melayu 
amat penting untuk merancang strategi pencegahan kebutaan dan rawatan yang lebih 
berkesan. Kajian ini dijalankan untuk menentukan tahap dan kadar keterukan POAG 
di kalangan pesakit POAG berbangsa Melayu. Selain dari itu, kajian ini juga 
bertujuan untuk menentukan peranan fungsi endotelial mikrovaskular dan genetik 
dalam menentukan tahap dan kadar keterukan POAG. 
Satu kajian keratan rentas telah dijalankan yang melibatkan 215 subjek berbangsa 
Melayu (114 pesakit POAG dan 101 kawalan). Keterukan POAG adalah berdasarkan 
analisa medan penglihatan Humphrey (HVF). Ketentuan kadar keterukan adalah 
berdasarkan kombinasi skor Kajian Intervensi Glaukoma Lanjutan (AGIS) dan 
klasifikasi Hodapp, Parish dan Anderson. Manakala tahap keterukan POAG adalah 
berdasarkan skor AGIS HVF yang telah diubah suai; tahap keterukan ringan, 
sederhana dan teruk.  
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Fungsi endotelial mikrovaskular juga turut dinilai menggunakan ‘Laser Doppler 
Fluximetry’ (LDF) dan proses iontoforesis mengunakan asetilkolina (ACh) dan 
natrium nitroprusida. Darah vena juga turut diambil dari pesakit glaukona bagi kajian 
genetik.  Ketulenan genom DNA yang tinggi juga telah diekstrakkan. Platform 
‘Microarray Human Omni Express-12’ telah digunakan untuk mengenalpasti 
penanda genetik bagi kadar keterukkan penyakit POAG. rs1392912 dan rs1660029 
dari gen KALRN, dan rs1210977 dari gen COL9A1 telah dikenalpasti sebagai 
penanda genetik yang berpotensi memainkan peranan dalam menentukan kadar 
keterukan penyakit  dan fungsi endotelial mikrovaskular. Polimorfisma nukleotida 
tunggal (SNPs) ini kemudiannya telah didedahkan kepada penjujukan DNA. 
Selepas purata 4.1 (3.0) tahun menjalani temujanji susulan didapati 35 pesakit 
menunjukkan perubahan dalam keterukan medan penglihatan. Berdasarkan kepada 
medan penglihatan semasa kajian ini dijalankan, 55 pesakit menunjukkan tahap 
POAG yang ringan, 29 sederhana dan 30 teruk. Terdapat pengurangan fungsi 
endotelial mikrovaskular yang signifikan dalam kalangan pesakit POAG berbanding 
kumpulan kawalan (p<0.001). Respon terhadap ACh dan s natrium nitroprusida 
berkurangan secara signifikan dalam kalangan pesakit yang mengalami POAG teruk 
(p<0.001). Terdapat juga pengurangan fungsi endotelial mikrovaskular yang 
signifikan di kalangan pesakit yang menunjukkan perubahan keterukan medan 
penglihatan (p<0.001). Didapati juga risiko perubahan keterukan penyakit POAG 
adalah 4.8 kali ganda (95% CI 1.52, 14.86) dalam kalangan pesakit dengan 
rs1392912GA dan 5.8 kali ganda (95% CI 1.85, 18.61) dalam kalangan pesakit 
dengan rs1660029AG. Walaubagaimana pun, tiada hubungkait variasi penanda 
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genetik rs1210977 dari COL9A1 dalam fungsi endotelial mikrovaskular pesakit 
Melayu yang menghidap POAG. 
Kadar keterukan penyakit POAG adalah 8.5 pesakit/tahun di kalangan pesakit 
Melayu. Fungsi endotelial mikrovaskular memainkan peranan dalam tahap dan kadar 
keterukan POAG dalam kalangan bangsa Melayu. rs1392912GA dari gen KALRN 
adalah penanda genetik yang berpotensi dalam menentukan perubahan keterukkan 
penyakit POAG. Terdapat kemungkinan bahawa penambahbaikan fungsi endotelial 
mikrovaskular dan pengesanan awal pesakit dengan variasi genetik gen KALRN 
dapat membantutkan kadar keterukan penyakit POAG dikalangan bangsa Melayu. 
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THE ROLE OF MICROVASCULAR ENDOTHELIAL DYSFUNCTION AND 
GENETICS ON SEVERITY AND PROGRESSION OF PRIMARY OPEN 
ANGLE GLAUCOMA IN MALAYS 
 
ABSTRACT 
 
There is lack of knowledge of clinical presentation and risk factor for primary open 
angle glaucoma (POAG) in Malays. Identification of the risk factors for severity and 
progression of POAG in Malays is important to strategies prevention of blindness 
and effective management. This study was conducted to determine the severity and 
progression of POAG in Malay patients and to determine the role of microvascular 
endothelial function and genetics in progression and severity of POAG.  
A cross-sectional study was conducted involving 215 Malay (114 POAG patients and 
101 controls) subjects. Progression was determined based on Humphrey visual field 
analysis (HVF) of 114 POAG patients using combination criteria of Advanced 
Glaucoma Intervention Study (AGIS) scoring and Hodapp, Parish and Anderson 
classification. Severity of POAG was based on modified AGIS scoring of HVF. 
Microvascular endothelial function was assessed using Laser Doppler Fluximetry 
(LDF) with the process of acetylcholine (ACh) and sodium nitroprusside 
iontophoresis. Venesection was also conducted. High purity genomic DNA was 
extracted. Microarray Human Omni Express-12 platform was used to identify genetic 
markers. rs1392912 and rs1660029 from KALRN gene, and rs1210977of COL9A1 
gene  were identified as potential markers for progression and microvascular 
25 
 
photoreceptor it has to pass through many layers. Once light reaches the 
photoreceptors, visual signal propagates back up to the ganglion nerves. These 
ganglion nerves, in turn course along the surface of the retina toward the optic disc 
and form the optic nerve running to the brain. Macula is pigmented area of the retina 
that responsible for central vision. Within the central macula lies the fovea, which is 
a small pit involves with extreme central vision. The fovea is very thin and derives its 
nutrition entirely from the underlying choroid. Choroid composed of blood vessels 
that lies right beneath the retina. Choroid supplies nutrition to the outer one-third of 
the retina which includes the rod and cone photoreceptors.  
Optic disc is the entry and exit point of the eye. The central retinal artery and vein 
pass through here, along with the ganglion nerves that form the optic nerve.  A 
physiologic divot or “cup” that is important in diagnosis and management of 
glaucoma. The optic nerve is made up of many nerve fibres, like an electrical cable 
containing numerous wires.  Once these fibres are damaged, blind spots develop.  
These blind spots usually go undetected until the optic nerve is significantly 
damaged.  
 
 
 
 
 
1. CHAPTER ONE 
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Glaucoma 
 
Cornea is the clear anterior surface of the eye. The cornea-air interface provides the 
majority of the eye’s refractive power. The cornea is avascular and gets its nutrition 
from tears on the outside, aqueous fluid on the inside, and from blood vessels located 
at the peripheral limbus. Iris, ciliary body, and choroid plexus are continuous with 
each other and are collectively known as uvea. Iris is coloured part of the eye and its 
primary function is to control the amount of light hitting the retina. The inner iris 
flows back and becomes the ciliary body.  
The ciliary body has two functions: it secretes aqueous fluid and controls the shape 
of the lens. The lens is placed posterior to the iris. Ithas no innervation or 
vascularization. The lens receives its nourishment entirely from nutrients floating in 
the aqueous fluid. It also has the highest protein concentration of any tissue in the 
body (65% water, 35% protein). The lens is held in place by suspensory ligaments 
called zonular ligaments that insert around the periphery and connect to the muscular 
ciliary body.  Contraction of the ciliary muscle causes the zonular ligaments to relax, 
allowing the lens to become rounder and increase its refracting power for close-up 
reading.  
Retina is the sensory portion of the eye that act as a film of camera. Retina contains 
layers of photoreceptors, nerves and supporting cells. For light to reach the 
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Figure 1-1: Cut section of the Eye, illustrating important anatomical structures 
(http://www.shutterstock.com/human+anatomy/search-vectors.html) 
 
The word "Glaucosis" was first introduced in Hippocratic work in early Greece in 
400 BC, as a disease resulting in blindness and occurring most commonly in the 
elderly. The term “Glaucosis” was used to describe various sight-threatening 
conditions in addition to glaucoma. In 1348, a Muslim scientist Sams-al-Din 
observed the elevation of intra-ocular pressure (IOP). However, his observation 
remained neglected for nearly three hundred years(Evans, 1939).Richard Bannister 
(1622), a renowned surgeon who wrote the first book on ophthalmology in English. 
He described glaucoma as an eye disease with a tetrad features: eye tension, long 
duration, no perception of light and a fixed pupil.’ (Keeler et al., 2013).  
In 1862, Donder described glaucoma as a disease of long duration with elevated 
pressure and fixed pupil (Haffmans and Schmidt, 1862). Later in 19th century, 
Antoine-Pierre Demours was the first to associate glaucoma with raised intra-ocular 
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tension (Arnold, 1963). For the past 700 years, the understanding of glaucoma has 
been further distinguished. Drance (Drance, 1960)introduced definition of glaucoma 
as a disease related to the optic nerve caused by several risk factors. 
Currently, glaucoma is considered to be a group of eye conditions that cause damage 
to the optic nerve (Casson et al., 2012; Resch et al., 2009) . Glaucoma is a complex 
disease with possibilities of various underlying mechanisms. Initially increased IOP 
was identified as a causative factor of glaucoma (Drance et al., 1973). However, with 
further understanding of the pathogenesis of glaucoma, IOP is considered as a risk 
factor; the only modifiable risk factor.  
In 1990, glaucoma was considered to be the third leading source of blind people in 
the world by World Health Organization (WHO) (JMJ, 2002; Thylefors and Negrel, 
1994). Glaucoma is responsible for 13% of world blindness, affecting approximately 
5 million people in the world (Thylefors and Negrel, 1994)The recent reports by 
WHO ranked glaucoma as the second most prevalent cause of blindness (Resnikoff 
et al., 2004). The number of people affected by glaucoma is expected to rise every 
year and may lead to a substantial public health challenge worldwide (Quigley, 
1996). It was estimated that 67 million people were affected by this condition in year 
2000 and over 6.7 million people were estimated to be bilaterally blind(Quigley, 
1996). This estimation was based on 111   studies in 7 stratified populations with 
clear definition of glaucoma, random selection of samples, and large sample size 
(Quigley, 1996).  
Prevalence of primary open angle glaucoma (POAG) is higher in African Americans 
and African Caribbean’s compared to Caucasians. The difference was attributed to 
racial difference (Leske et al., 1994). However, race is a complex and controversial 
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concept, which involves genetics, religion, culture, language, anthropology, 
geographic locations, inhabitant environment and population history(Wilson, 2003). 
Thus it is inappropriate to conclude that the observed difference in the prevalence of 
POAG is due to potential differences in environmental exposure, genetic 
predisposition or other factors (Kosoko-Lasaki et al., 2006a). Such differences that is 
environmental exposure, genetic predisposition or other factors may occur between 
different ethnic groups of the same "race" as well. The prevalence of glaucoma has 
been studied extensively and has been shown to vary extensively between ethnic and 
racial groups (Quigley and Broman, 2006; Ramakrishan et al., 2013; Rudnicka et al., 
2006).  
Population based studies have shown estimated prevalence rates varying greatly 
between different populations ; ranging from 1-3% in Europe, 2-3% in Australia, 1-
4% in Asia (Quigley and Broman, 2006; Rudnicka et al., 2006). Higher prevalence of 
7-9% was reported among African Caribbean’s originating from West Africa (Leske 
et al., 1994; Mason et al., 1989).  
 The risk of developing glaucoma is increases exponentially with increasing age 
(Friedman et al., 2004). This is most probably due to the improvement in health 
system and facilities. It was projected that over 8.4 million of the population will be 
bilaterally blind due to glaucoma in 2010 and further increases to 11.1 million by 
2020 worldwide (Quigley and Broman, 2006). Based on 8 population based studies 
that include the Beaver Dam Eye Study, Barbados Eye Study (BES), Baltimore Eye 
study, Blue Mountain Eye Study (BMES), Proyecto Vision Evaluation Research, 
Kongwa Eye Project, Rotterdam Study, and the Melbourne Visual Impairment 
Project, the prevalence of glaucoma has been extrapolated to affect 3.36 million 
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Caucasians by 2020 (Friedman et al., 2004). Glaucoma is often asymptomatic and 
result in substantial visual damage before diagnosis is made (Fraser et al., 2001). 
Late presentation is common and identified as a significant risk factor for a 
consequent blindness in glaucoma (Fraser et al., 2001). 
Among different subtypes of glaucoma, POAG is the commonest and responsible for 
more than 50% of all cases of glaucoma (Pang et al., 2006). It is estimated that 
around 50% of patients with POAG remain undiagnosed in most Western 
communities (Kroese et al., 2002). Visual acuity may not deteriorate significantly 
until advance stage of the disease, hence responsible for its delayed diagnosis or non-
diagnosis (Topouzis, 2007).  
Quigley and colleagues estimated that in 2010 half of the world’s glaucoma patients 
were in Asia (Quigley and Broman, 2006). Even though more emphasis has been 
given to angle closure glaucoma (ACG), OAG is still the most common glaucoma in 
Asia (Foster and Johnson, 2001; Quigley and Broman, 2006). In population-based 
surveys in East Asia, Foster et al (2001) found higher rate of severe monoocular 
visual field loss from PACG patients than POAG patients (Foster and Johnson, 
2001). PACG caused approximately 45% of monocular blindness (He et al., 2006), 
whereas POAG rates of severe vision loss were considerably lower (17%) (He et al., 
2006).  The highest number of people affected by both ACG and OAG are in Asia 
followed by Europe(Quigley and Broman, 2006).  
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1.1.1 Definition of glaucoma 
 
Diagnosing glaucoma remains a challenge due to inconsistent definition of glaucoma. 
This has generated a problem in not only its detection but also to determine its type 
and to institute appropriate treatment and to accurately assess its prevalence. Proper 
definition of disease is the foundation of epidemiological research whether 
measuring prevalence, studying risk factors, and or conducting clinical trials. In the 
past, definition included specific levels of IOP as the criteria, the definition has 
evolved for the past 30 years (Leske, 1983).Most of the population based studies 
defined glaucoma with special interest in structural changes of optic nerve head 
(ONH) and functional defect of visual fields, without specific reference to intra 
ocular pressure (IOP) (Mitchell et al., 1996; Tielsch et al., 1995; Tielsch et al., 
1991b). 
IOP was then identified as a modifiable risk factor and not consider as a criteria for 
diagnosis of glaucoma (Sommer, 1989). Approximately 20% of subjects with open-
angle glaucoma have their IOP within normal range (Bonomi et al., 1998). Over the 
age of 40, around 2 in every 100 people developed open angle glaucoma but around 
4 in 100 over 40 years developed ocular hypertension in the Blue Mountains Eye 
Study and the Melbourne Visual Impairment Project (Rait, 2014). Ocular 
hypertension was defined as an IOP above 21 mm Hg by applanation tonometry on 
repeated testing in the absence of typical glaucomatous field defects(Perkins and 
Phelps, 1982).Therefore, diagnosing glaucoma solely on IOP level may lead to over 
or under estimation.  Most studies defined glaucoma based on vertical cup disc ratio 
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(VCDR) and visual field defects (Klein et al., 1992; Leske et al., 1994; Tielsch et al., 
1991b).  
In some studies patients were further categorized as definite POAG and suspected 
cases on the basis of VCDR and previously obtained visual field (Dandona et al., 
2000; Foster et al., 2000). International Society of Geographical and Epidemiological 
Ophthalmology (ISGEO) formed a special panel to develop a consensus on definition 
of glaucoma (Paul J Foster, 2002) . It is based on prevalence studies but has been 
adopted in many clinical studies. The definition was formulated from structural and 
functional evidence of glaucomatous damage (category 1 and 2). IOP and visual 
acuity along with visual acuity is considered as part of  definition (category 3 and 4) 
when it is practically impossible to diagnose patients on structural and functional 
basis (Foster et al., 2002).  
Primary open angle glaucoma (POAG) is chronic, progressive optic neuropathy 
defined by changes in the optic nerve head (ONH) and visual field in the absence of 
primary causes (SEAGIG Glaucoma Guideline 2nd edition, 2008) (Brandt et al., 
2012). The relation between vertical cup-disc ratio (VCDR) and corresponding visual 
field abnormalities is complex (Foster et al., 2002; Hoffmann et al., 2007). Some 
patients have reproducible field defects but have a CDR that lies within normal range 
(Foster et al., 2002).  VCDR is well known to vary widely within the normal 
population (Jonas et al., 1988a). There wasalso significant overlap in VCDR between 
normal and glaucomatous eyes. In a study by Jonas and colleagues, normal VCDR 
ranges up to 0.87(Jonas et al., 1988a). It is well established that the vertical cup 
diameter increase in association with optic disc size (Bengtsson, 1976).  Using 0.7 as 
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the cut off could potentially lead to high numbers of false negative in eyes with small 
optic discs and high numbers of false positive in larger optic discs.  
The characteristic visual field defects are defined as asymmetrical points across 
horizontal midline located in the mid-periphery, clustered in neighbour test points, 
reproducible on at least two occasions and the visual field defects are  not explained 
by any other disease (Foster et al., 2002). However, these principles failed to address 
the characteristic visual field defect in severe cases. Thus, in severe cases, the 
glaucoma hemifield test graded as outside normal limits and a cluster of three 
contiguous points at the 5% level on the pattern deviation plot, using the threshold 
test strategy with 24-2 test pattern of Zeiss-HVF analyser 2 (Foster et al., 2002).  
The central idea of the suggested definition by International Society for Geographical 
and Epidemiological Ophthalmology is that the term glaucoma can be used only for 
people with recognizable, visually significant end organ damage and glaucoma can 
be characterized as an optic neuropathy associated with characteristic structural 
damage to the optic nerve with visual field loss that may be caused by various 
pathological processes.  This diagnostic scheme limits the features required to make 
the diagnosis to direct measurements of the structure and function of the optic nerve. 
1.1.2 Pathogenesis of Glaucoma 
 
The concept of elevation of IOP in glaucoma was identified by the Arabs in the 10th 
century (AI Tabari), and in 1626 by Bannister (Keeler et al., 2013). It was further 
emphasized by Mackenzie in 1830 (Duke-Elder and Jay, 1969). However, it was only 
after the publication of the work by Antoine-Pierre Demours (Arnold, 1963),  that the 
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concept of increased IOP in glaucoma was fully established (Duke-Elder and Jay, 
1969).  For nearly 150 years, importance was given to IOP in the diagnosis of 
glaucoma. Only recently emphasis was given to the appearance of the optic disc and 
visual field loss.  
The new concepts or theories of glaucoma evolved when patients with normal IOP 
developed typical visual field patterns with characteristics cup disc changes (Drance, 
1972; Leighton and Phillips, 1972b; Sjögren, 1946). These theories were against the 
pressure-dependent theory. In addition, lowering intraocular pressure (IOP) alone 
would not retard progression of glaucoma (Mozaffarieh and Flammer, 2007; Tezel et 
al., 2001). Pressure independent mechanism include inadequate perfusion of optic 
nerve head due to damage to microvascular endothelial cells may be more relevant 
(Adams, 2006; Grieshaber et al., 2007b; Kaushik et al., 2003; Nicolela et al., 2003). 
Other possible pressure-independent mechanisms responsible for initiation and 
progression of glaucoma include oxidative stress (Izzotti et al., 2003a; Sacca et al., 
2005), excitotoxicity (Kaushik et al., 2003), abnormal glial-neuronal interactions 
(Tezel and Wax, 2000), neurotrophin starvation (Schuettauf et al., 2002),  and 
autoimmunity (Maruyama et al., 2000) is believed to contribute to the initiation and 
progression of glaucoma. Genetics has also been identified as predisposing factor 
(Caprioli and Garway-Heath, 2007). 
The pressure-dependent theory suggests the direct effect of mechanical pressure on 
axonal fibres. Pressure-independent theory focuses on decreased perfusion and 
development of intraneural ischaemia due to vascular resistance. Glaucoma is a 
multi- factorial disease with a final common pathway leading to optic nerve damage 
and visual field loss. Until now, there is no specific pathogenesis of glaucoma. 
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Glaucoma is generally accepted as neurodegenerative disease that is caused by 
various mechanisms. Based on the status of the angle structure of the eye, glaucoma 
is categorized as open angle glaucoma (OAG) and angle closure glaucoma (ACG). 
These classifications are further divided on the basis of aetiology: primary are those 
without any other known cause and secondary are those associated with other 
systemic pathologies. 
1.1.2.1 Mechanical Theory 
 
Currently the main aim of therapeutic treatment of glaucoma is to lower the IOP in 
order to retard the progression of ONH damage and visual field loss (NICE-CG85, 
2009). Without doubt IOP is a relevant pathogenic feature in the development of 
GON (Nathan, 2000). 
IOP is a mechanical entity, referring to the normal force per unit area applied by the 
intraocular fluids on the structure of the eye (Sigal and Ethier, 2009). It is indistinct 
whether alterations to the ONH are the primary event that precipitates retinal 
ganglion cell (RGC) damage or glaucomatous RGC death prompts the events that 
lead to ONH changes. There are evidences that indicate elevation of IOP trigger 
distinct compositional and structural changes in the ONH. These include increased 
synthesis of several extracellular matrix molecules such as tenascin (Pena et al., 
1999; Ricard et al., 1999), matrix metalloproteinases (Ricard et al., 1999), NCAM-
180 (Ricard et al., 2000), collagen IV, and elastin (Hernandez and Pena, 1997).  In 
vitro studies found that reactive astrocytes may be responsible for remodelling of the 
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extracellular matrix (Hernandez and Pena, 1997; Ricard et al., 2000). Reactive 
astrocytes drift to the nerve bundles is  induced by increased IOP and may form big 
cavernous spaces through the expression of matrix metalloproteinases (proteolytic 
enzymes) (Guo et al., 2005; Ricard et al., 1999). The changes in the architecture of 
extracellular matrix may weaken the ONH and facilitate the collapse of the lamina 
cribrosa beams, ultimately leading to injury of the RGC axons that pass through these 
structures.  
It is a widely accepted that lamina cribrosa is the site of early damage to the 
ganglion-cell axons (Gaasterland et al., 1978; Quigley and Addicks, 1981). The 
lamina cribrosa consists of ten lamellar connective tissue sheets with apertures to 
allow passages for the axons of ganglion-cells (Quigley and Addicks, 1981; Radius 
and Gonzales, 1981). Raised IOP is proposed to push lamina cribrosa posteriorly 
(Levy and Crapps, 1984) with movement of the connective tissue layers in relation to 
each other and this change leads to narrowing of laminar apertures (Quigley et al., 
1981). The changes in lamina cribrosa are responsible for mechanical pressure to the 
nerve fibres that run through the apertures. This leads to the obstruction of 
anterograde and retrograde axoplasmic flow in neurons and subsequent neuronal 
death after duration of mechanical pressure (Gaasterland et al., 1978; Quigley and 
Addicks, 1980). The overall susceptibility of the ocular structures to the effects of 
IOP however, appears to vary between individuals as a function of the individual 
eye’s anatomy and composition (Bandyopadhyay et al., 2011; Sigal and Ethier, 
2009). 
Both experimental as well as clinical studies have established the role of IOP and the 
benefits of IOP lowering treatment (AGIS, 2000). Evidence support that reduction in 
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IOP may improve the prognosis of patients but do not halt the progression in all 
patients. The postulation that IOP is the only causative factor is being increasingly 
challenged (Flammer, 1996). Normal-tension glaucoma (NTG) and ocular 
hypertension (increased IOP without recognizable damage) indicate that other factors 
are also involved in the pathogenesis of glaucomatous optic neuropathy (GON). 
 NTG incidence in women is twofold higher than men (Orgul et al., 1995).  African 
descent glaucoma patients have average IOP almost similar of Whites, yet the 
prevalence of glaucoma is four times higher (Sommer et al., 1991b). NTG is the 
commonest type of glaucoma in Japan (Araie et al., 1994) . The incidence rate of 
GON among Japanese is similar to Caucasian (Shiose, 1990) . Paradoxically, IOP 
diminishes with advancing age in Japan (Shiose, 1990).  However it should be noted 
that despite this, Japanese patients with elevated IOP, like their Western counterparts, 
are more likely to have progressive GON than those with normal IOP (Shiose et al., 
1990). All these observations cannot be satisfactorily explained by the pressure 
theory alone, indicating that increased IOP is not necessary for the development of 
GON (Flammer and Orgül, 1998). Some eyes with high IOP may not develop 
disease; approximately 20% of subjects with open-angle glaucoma have IOP within 
normal range (Bonomi et al., 1998; Lundberg et al., 1987; Sommer et al., 1991b). 
This raises a question: is it possible that at a given pressure level, the majority of 
people will never suffer GON, while others do? Furthermore, why glaucoma 
progression is only weakly related to IOP? (Martínez-Belló et al., 2000). Finally 
pressure reduction, although significantly improves prognosis but it does not avoid 
damage in all patients (Stewart et al., 2000). 
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1.1.2.2 Vascular mechanism 
 
Duke-Elder described that glaucomatous visual field defects and optic disc cupping 
sometimes occur without raised intra-ocular tension, stressing the vasogenic factor in 
glaucoma (Duke-Elder, 1953) and considered instability of vascular control as an 
aetiology of glaucoma.Hayreh reported that the nerve fibre bundle defects and 
cupping of optic disc are due to damage of vessels in the prelaminar part of the optic 
disc and peripapillary choroid. Peripheral visual field constriction is due to the 
involvement of the peripheral centripetal vascular system to this part of the optic 
nerve (Hayreh, 1969) 
A pressure independent mechanism mainly focused in the imbalance of optic nerve 
head (ONH) perfusion causing ischemia of ONH (Osborne et al., 1999, Flammer, 
1994; Flammer and Orgül, 1998). Based on this theory, reduction in perfusion of 
optic nerve head (Flammer, 1994; Flammer and Orgül, 1998) and ischaemia induced 
ONH damage and retinal ganglion cell death contributes to GON (Osborne et al., 
1999).   
Ocular perfusion pressure (OPP) is dynamic but can be mathematically calculated; 
the difference between systemic blood pressure and intraocular pressure (IOP). OPP 
is affected by the resistance to flow and regulated by the size (calibre) of vessel 
lumen (Flammer, 1994). Vascular resistance plays a role in determining the amount 
of blood that flows through a vascular bed. Vascular resistance itself is affected by 
blood viscosity, vessel length and vessel diameter (Delaey and Van de Voorde, 
2000). Due to constant capillary perfusion and lack of pre capillary sphincters in 
retinal vascular bed, alterations in the length of vessel are believed to not play a role 
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in the regulation of ocular blood flow (OBF)  (Delaey and Van de Voorde, 2000; 
Henkind and De Oliveira, 1968). In spite of the alterations in blood viscosity have 
been found to substantially influence retinal blood flow but such alterations do not 
occur without the presence of underlying pathology, such as sickle cell anaemia and 
other blood disorders (Perry and Hoagland, 1976). Blood viscosity may not play 
significant role in regulation of OBF in healthy subjects.  
Vessel diameter plays a major role in determining retinal vascular resistance and 
OBF (Delaey and Van de Voorde, 2000). According to Poiseuille’s Law vascular 
resistance is known to be inversely proportional to the 4th power of a blood vessel 
radius (Hayreh, 2008). A small change in vessel diameter can significantly influence 
vascular resistance. For example, a 2-time increase in radius results in decreases of 
resistance by 16-time. Therefore, vessel resistance is precisely sensitive to changes in 
radius. Reduction or unstable OBF could therefore occur, not only because of 
reduced OPP, but also because of an increase in vascular resistance due to alterations 
in vessel diameter (Flammer et al., 2002).  Changes in vessel diameter may occur due 
to structural or mechanical changes in the vessel wall and in the presence of a 
functional dysregulation. 
Autoregulation is believed to be responsible for maintaining optic nerve head 
perfusion (Flammer et al., 2001; Moore et al., 2008). Autoregulation refers to the 
ability of the vascular system to modify vascular resistance in order to maintain a 
constant blood supply despite variations in perfusion pressure (Johnson, 1986). 
Autoregulation is present in retinal, ONH and choroidal circulation (Dumskyj et al., 
1996; Movaffaghy et al., 1998; Polska et al., 2007). The basic mechanisms 
underlying autoregulation are still unclear. The proposed mechanisms include 
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metabolic, myogenic, neurogenic and humoral factors in the ocular circulation 
(Johnson, 1986; Pournaras et al., 2008).  Endothelial derived vasoactive agents are 
also believed to play a role in autoregulation (Johnson, 1986; Pournaras et al., 2008).  
A tight coupling mechanism is thought to exist between tissue metabolism and ocular 
perfusion.  Alterations in the local concentrations of metabolites such as O2, CO2, 
potassium and hydrogen may influence ocular vascular tone (Johnson, 1986). Partial 
oxygen pressure (pO2) has been identified as one of the main driving force behind 
metabolic autoregulation (Kontos et al., 1978). Systemic hyperoxia causes reduction 
in blood flow and pO2 to retina and ONH by vasoconstriction (Gilmore et al., 2005; 
Harris et al., 1996). However, hypoxic conditions increased retinal blood flow and 
allowing normalisation of pO2 by vasodilatation (Eperon et al., 1975). The 
haemodynamic response of the retinal vasculature to hyperoxia is thought to be 
mediated by endothelin (Takagi et al., 1996). Endothelial derived vasodilator factors 
are believed to be responsible for hypoxia-induced vasodilatation of the retinal 
vasculature (Busse et al., 1983).  
In general, myogenic autoregulation is considered to be mechanically independent of 
the endothelium and is considered as intrinsic function of vascular smooth muscle 
cells. Stretching of the vessel wall causes depolarisation of the smooth muscle cells 
membrane and that leads to vasoconstriction (Schubert and Mulvany, 1999). In the 
cerebral circulation, however, myogenic induced vasoconstriction has also been 
suggested to be at least partly mediated by endothelial factors (Harder, 1987). 
Myogenic regulation has been found in the ONH and retina (Weinstein et al., 1983). 
The eye has a rich autonomic innervation but not in the retina and prelaminar portion 
of the ONH (Laties, 1967; Ye et al., 1990). Stimulation of sympathetic innervation 
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triggers constriction of the choroidal blood vessels and increases choroidal vascular 
resistance during the periods of increased heart rate or blood pressure (Bill and 
Linder, 1976). It has been suggested that vasoconstriction of the uveal vasculature 
may protect the eye against over perfusion (Bill, 1962). Parasympathetic innervation 
stimulates vasodilatation response of choroidal vasculature and increase blood flow 
to ONH (Ehinger, 1966). Humoral control refers to the potential regulatory influence 
of numerous vasoactive agents present in the circulating blood. The effect is through 
either direct interaction with the vascular smooth muscle cells and pericytes or 
through mediation of endothelial cells causing changes in OBF (Rossitti et al., 1995). 
Endothelium plays an important role as an active regulator of vascular tone 
(Bassenge and Busse, 1988; Furchgott and Zawadzki, 1980). Endothelium also play a 
role as inhibitor of vascular smooth muscle cell proliferation, regulator of 
inflammation, thrombosis and platelet aggregation, angiogenesis and controls the 
vascular permeability (Deanfield et al., 2007; Landmesser et al., 2004). The role of 
endothelium as an active regulator of vascular tone is accomplished through 
endothelial derived vasoactive factors. Nitric oxide (NO) and endothelin-1 (ET-1) 
has been identified as the most potent vasodilator and vasoconstrictor 
respectively(Haefliger et al., 1992). 
Ischaemia or vascular dysregulation occurs as a consequence of an imbalance 
between NO and ET-1 (Su et al., 2006). According to the vascular theory, chronic 
reduction of blood supply to the ONH results in ganglion cell damage (Flammer, 
1994). So it is advocated that reduced ONH blood flow, as experienced in glaucoma 
patients (Findl et al., 2000) is related to an altered endothelial function in the 
supplying vessels (Haefliger et al., 1999; Haefliger et al., 1994b).  Constant 
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formation of NO by the endothelial and neuronal isoforms of the enzyme NO 
synthase (NOS) helps in the regulation of a basal vasodilator tone in the optic nerve 
head (Haefliger et al., 1993; Luksch et al., 2000). Changes in NO formation may 
shift the balance between vasodilator and vasoconstrictor endothelial agents causing 
alteration of blood supply leading to ischaemia of ONH (Hayreh, 2008). 
1.1.2.3 Oxidative stress 
 
Oxidative stress is an imbalance between the production of oxidants and 
antioxidants, in favour of the former, with the potential for damage or having too 
many reactive oxygen species (ROS) in relation to the available antioxidants is said 
to be a state of oxidative stress (Halliwell, 2006; Sies, 1997). Oxidation is a harmful 
process biochemically due to the loss of electrons and/or gain of oxygen by a 
molecule and is brought about by the action of oxidizing agent or oxidants 
(Halliwell, 2006). Oxidizing agent may take the form of free radicals when there is 
one or more of unpaired electrons, which are usually highly reactive. It can also be 
present as non-radical species, derived from either oxygen (reactive oxygen species, 
ROS) or nitrogen (reactive nitrogen species, RNS).  
The retinal ganglion cells (RGCs) and axons of the ONH are considered particularly 
susceptible to oxidative stress due to their direct exposure to light, their high 
proportion of polyunsaturated fatty acids and high levels of oxygen (O2) 
consumption. In addition, the lack of myelin sheaths in RGCs and high concentration 
of mitochondria in axons of ganglion cells further increase the susceptibility to 
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oxidative stress (Chan, 2014). Oxidative stress has been implicated to play a 
causative role in the elevation of IOP and subsequent development of GON 
(Mozaffarieh et al., 2008). Several studies have demonstrated depletion of total 
antioxidant potential and enhanced antioxidant activity in the aqueous humour and 
the presence of oxidative damage in the trabecular meshwork (TM) cells of glaucoma 
patients (Bunin et al., 1991; Ferreira et al., 2004; Ghanem et al., 2010; Izzotti et al., 
2003b; Kahn et al., 1983; Sorkhabi et al., 2011; Wang et al., 2001). This suggests the 
potential evidence of oxidative stress as a pathogenesis of glaucoma.  
Astrocytes are found in the ONH and provide biochemical support to the RGC axon 
(Wilson and Di Polo, 2011). They have a high susceptibility to reactive oxygen 
species (ROS). ROS are chemically reactive molecules that contain oxygen, for 
example per oxide, super oxide and hydroxyl redical. ROS on activation, start 
producing a variety of abnormal molecules that include NO and ET-1 hence altering 
the microenvironment of the cell (Prasanna et al., 2011). Diffusion of NO from the 
astrocytes into the neighbouring RGC axons, where levels of ROS such as O2 are 
high can lead to the formation of very damaging peroxynitrate (ONOO-)  (Neufeld et 
al., 1997). It is proposed that subsequent diffusion of both O2 and ONOO- within the 
RGC axons, towards the retina and LGN trigger the apoptotic loss of RGCs 
(Feilchenfeld et al., 2008; Flammer and Mozaffarieh, 2007; Luthra et al., 2005). 
Astrocytes become activated due to elevated IOP through direct mechanical effect, or 
indirectly by the apoptosis of RGC axons via disruption of axoplasmic transport and 
deprivation of essential growth factor (Liu et al., 2006; Zhang and Neufeld, 2005). In 
addition, elevated ET-1 levels as part of the changes of the raised IOP may also 
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trigger the activation of astrocytes and initiate the apoptosis of RGC and their axons 
(Prasanna et al., 2011). 
Unstable blood flow and or alteration of autoregulation in the ocular and systemic 
circulation may lead to ischaemia of ONH (Hayreh, 2008). The absence of oxygen 
during ischaemia leads to impairment in electron transport in the mitochondria that 
result in inefficient energy production and production of extra electrons. 
Improvement in the perfusion leads to the reaction of these spare electrons with the 
available now plentiful supply of O2 molecules, leading to the formation of 
damaging ROS (Grace, 1994). Mitochondria are abundant in the RGC axons of the 
ONH putting it at higher risk of damage by ROS. The development of mild recurrent 
reperfusion injury that continues over a sustained length of time may initiate chronic 
oxidative stress, endothelial dysfunction, ONH damage and the development of GON 
(Flammer and Mozaffarieh, 2007; Mozaffarieh et al., 2008). 
1.2 Severity of POAG 
 
Most people with open-angle  glaucoma do not notice any change in vision at the 
early stage of the disease due to the central vision and sharpness is maintained. In 
addition, any initial loss in visual field is barely perceptible in the peripheral vision. 
By the time the patient perceives any symptoms of vision loss, the disease is quite 
advanced, and the damage is permanent. Even if detection is made at the early stage, 
effective medications such as eye drops or surgical intervention can at best retard 
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further progression. Untreated, glaucoma can severely restrict the visual field and 
irreversible blindness (Hattenhauer et al., 1998). 
Staging the severity of GON damage is an essential component in treatment 
decisions making and providing visual prognosis to the patients (Medeiros et al., 
2012a). Stages of GON can be divided into mild, moderate, and severe (Hodapp et 
al., 1993).  Staging of severity enables an ophthalmologist to monitor progression 
(Susanna Jr and Vessani, 2008). Patients with severe damage are at increased risk of 
developing functional impairment and require more aggressive interventions 
(Medeiros et al., 2012a). Severe glaucoma needs aggressive treatment to reach target 
pressure. Target intraocular pressure can be defined as the level of intraocular 
pressure associated with minimal probability of pressure induced visual field or optic 
nerve damage, or of the existing damage progression (Popovic-Suic et al., 2005), The 
5-year probability of glaucoma development was 4.40% in the group of patients with 
20% reduction from the initial intraocular pressure, and 9.50% in the control group 
without intraocular pressure reduction in OHTS (Palmberg, 2002). Similarly early 
manifest glaucoma treatment (EMGT)study showed that 25% reduction from the 
initial intraocular pressure decreased the risk of progression by 25% (Heijl et al., 
2002). The AGIS investigators report on a 20% decrease from initial intraocular 
pressure or intraocular pressure decrease to < 18 mmHg in advanced glaucoma to be 
a useful strategy to achieve a desirable level of intraocular pressure (AGIS, 2000).  
Currently standard automated perimetry (SAP) is considered as the gold standard for 
the quantification and progression of glaucoma functional loss (Brusini and Johnson, 
2007). In addition to its role in clinical care, visual field assessment has traditionally 
been chosen as the primary endpoint in most clinical trials evaluating disease 
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progression and severity (Medeiros et al., 2012b). Several methods have been 
suggested to stage glaucoma severity over time using different approaches. These 
approaches can be broadly divided into two categories: event- versus trend-based 
methods (Hitchings, 2007). For event-based analysis, the criterion for progression 
(the event) is defined at the start of the study, and progression is confirmed when VF 
changes fall below a pre-set threshold, compared with baseline (Hitchings, 2007). 
Trend analysis evaluates all of the visual field results that have been collected over a 
series of sequential examinations via techniques for linear regression (Spry and 
Johnson, 2002). 
Detection of advanced glaucoma at the initial presentation increases the annual health 
budget due to multiple medications and also surgery may be required to halt the 
progression and retaining useful vision (Lee et al., 2007). Numerous SAP staging 
systems of glaucoma severity have been developed in the past three decades (Brusini, 
1995; Gandolfo, 1987; Hodapp et al., 1993; Investigators, 1994; Mills et al., 2006; 
Musch et al., 1999).  
 
 
1.3 Progression of glaucoma 
 
Determination and monitoring of glaucoma progression remains a challenge to the 
ophthalmologists and researchers.  This is due to the absence of a standard 
independent reference that provide a precise assessment and monitoring of 
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progression. An ideal method must be able to give useful information on visual field 
defects objectively and it should be reproducible and user friendly. In general, 
progression is based on structural and functional changes of the ONH (Hood and 
Kardon, 2007; Kourkoutas et al., 2014). The classification system for progression 
should be consistent with the structural damage and able to detect even a small 
functional loss (Susanna Jr and Vessani, 2008). There are many examples of standard 
automated perimetry methods to detect progression (Brusini, 1995; Gandolfo, 1987; 
Hodapp et al., 1993; Investigators, 1994; Mills et al., 2006; Musch et al., 1999; 
Quigley et al., 1996).To assess progression, clinicians have long relied on tests of 
function such as visual fields (VF) and optical coherence tomography (OCT) allow 
them to quantify structural component of eye. CIGTS and OHTS support the view 
that structural damage may be a more sensitive indicator of glaucomatous 
progression than functional damage in patients with glaucoma or ocular hypertension 
(OHT) (Kass et al., 2002; Parrish et al., 2009). However, in many cases functional 
damage was the first sign of glaucomatous development in OHT eyes (Kass et al., 
2002). Several investigators have reported that changes in the optic nerve head 
precede visual field loss (Drance, 1978; Hart et al., 1978)but recently investigations 
have reported the opposite: functional glaucomatous deficits can occur before 
structural changes (Harwerth et al., 2007; Hood and Kardon, 2007). Hood and 
colleagues presented a model of GON damage in which they showed that either 
structural or functional damage can occur prior to each other (Hood and Kardon, 
2007). Structural tests like OCT and functional tests such as VF perform better and 
provide more useful information at different severity stages of the GON (Medeiros et 
al., 2012c). VF usually performs poorly at detecting early damage in glaucoma and 
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underestimates the rate of progression that may be occurring. But like VF, OCT has 
its limitations. As disease advances, OCT becomes ineffective and can’t detect any 
further damage or progression (Medeiros et al., 2012c). 
Since glaucoma is a chronic progressive disease, progression occurs over a period of 
time. Determination of progression requires long observation and monitoring.  Some 
patients will progress very slowly and need only minimal therapy and others progress 
at faster rates that will quickly lead to visual disability (Ahrlich et al., 2010). Nearly 
half of the patients with open angle glaucoma showed progression despite treatment 
(Erdem et al., 2015). EMGT showed that 45% of patients continue to show glaucoma 
progression even with IOP lowering treatments (Leske et al., 2003). EMGT showed 
that progression rate of OAG treatment group was 45% as compared with 62% in the 
control group (Heijl et al., 2002). In another study on angle closure glaucoma in 
Malays found that 26% of patients with IOPs of 13–21 mmHg progressed in five 
years of follow-up period (Liza-Sharmini et al., 2009). The overall progression rate 
for POAG was 1.31(SD+/-1.93) (Heijl et al., 2009). In the Collaborative Initial 
Glaucoma Treatment Study (CIGTS), Lichter and associates found that visual field 
loss occurred in 10%–13.5% of participants during 5 years of follow up (Lichter et 
al., 2001). Collaborative Normal Tension Glaucoma Study (CNTGS) study reported 
a mean progression of -0.39dB per year and 33% of all patients progressed 
(Anderson et al., 2003). 
The major obstacle in monitoring progression is the lack of uniformly accepted, 
sensitive and specific criteria to detect glaucoma progression over time. Evaluation 
of VF defects and monitoring visuals fields and comparing them with previous fields 
remains the clinical method most frequently used to assess the severity and 
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progression of glaucoma and effectiveness of treatment.  Structurally, new or 
progressive thinning or haemorrhage of neural rim, saucerization of cup and 
functionally, glaucomatous visual field worsening (Seidel’s, paracentral, arcuate 
scotoma or nasal step, as well as appearance of altitudinal defect, temporal island, or 
deep diffuse depression) are generally considered as criteria’s for progression of 
glaucoma(Liza-Sharmini et al., 2009). Serial visual field assessment is used to 
determine the functionally changes. 
Perimetry is the technique used to measure the sensitivity (or extent) of the visual 
field (Besharse and Bok, 2011). Perimetry is divided into static and kinetic 
depending on whether or not the stimulus moves. Goldmann perimetry is a common 
example of kinetic perimetry.  The Humphrey Field Analyser (HFA) is a common 
example of static perimetry. In fact, both perimeters have the capability of doing both 
tests, but in practice Goldmann is used for kinetic perimetry and HFA for static. 
Perimetry can also be categorized as automated or manual, depending on whether the 
stimulus location is changed by a computer as in the Humphrey visual field (HVF), 
or if stimulus is moved by hand, as in the Goldmann (Dersu et al., 2006). Automated 
perimetry is a static perimetry, measuring the central 25-30º of the uniocular visual 
field (figure 1.2). However Esterman visual field perimetry is a binocular ocular 
testing method which examines more than 130° of the field is also available on HFA 
(Ayala, 2012) (figure 3). The principle of automated perimetry is based on 
identification of light stimuli of varying different intensities at various retinal 
locations while the patient fixates on a central target (Wroblewski et al., 2014). The 
location and intensity of stimuli observed by the patients are recorded based on their 
responses (Heijl and Patella, 2002). Loss of sensitivity in the visual field is a direct 
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indicator to the loss of signal carrying retinal ganglion cell (RGC) axons and 
dendrites that determines the effective functional loss experienced by the patient 
(Heijl, 2000). 
